Singh A - Search Results

1

Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in KRAS mutant mesenchymal-like NSCLC cells.

Mehta AK, Hua K, Whipple W, Nguyen MT, Liu CT, Haybaeck J, Weidhaas J, Settleman J, Singh A. Mehta AK, et al. Among authors: singh a. Sci Signal. 2017 Sep 12;10(496):eaam6291. doi: 10.1126/scisignal.aam6291. Sci Signal. 2017. PMID: 28900044 Free PMC article.

2

MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.

McNew KL, Whipple WJ, Mehta AK, Grant TJ, Ray L, Kenny C, Singh A. McNew KL, et al. Among authors: singh a. Mol Cancer Res. 2016 Dec;14(12):1204-1216. doi: 10.1158/1541-7786.MCR-16-0173. Epub 2016 Sep 21. Mol Cancer Res. 2016. PMID: 27655129 Free PMC article.

3

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Singh A, Settleman J. Singh A, et al. Oncogene. 2010 Aug 26;29(34):4741-51. doi: 10.1038/onc.2010.215. Epub 2010 Jun 7. Oncogene. 2010. PMID: 20531305 Free PMC article. Review.

4

Molecular Pathogenesis of Pancreatic Cancer.

Grant TJ, Hua K, Singh A. Grant TJ, et al. Among authors: singh a. Prog Mol Biol Transl Sci. 2016;144:241-275. doi: 10.1016/bs.pmbts.2016.09.008. Epub 2016 Oct 15. Prog Mol Biol Transl Sci. 2016. PMID: 27865459 Free PMC article. Review.

5

TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.

Singh A, Sweeney MF, Yu M, Burger A, Greninger P, Benes C, Haber DA, Settleman J. Singh A, et al. Cell. 2012 Feb 17;148(4):639-50. doi: 10.1016/j.cell.2011.12.033. Cell. 2012. PMID: 22341439 Free PMC article.

6

EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation.

Wang M, Kern AM, Hülskötter M, Greninger P, Singh A, Pan Y, Chowdhury D, Krause M, Baumann M, Benes CH, Efstathiou JA, Settleman J, Willers H. Wang M, et al. Among authors: singh a. Cancer Res. 2014 May 15;74(10):2825-34. doi: 10.1158/0008-5472.CAN-13-3157. Epub 2014 Mar 19. Cancer Res. 2014. PMID: 24648348 Free PMC article.

7

STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines.

Grant TJ, Mehta AK, Gupta A, Sharif AAD, Arora KS, Deshpande V, Ting DT, Bardeesy N, Ganem NJ, Hergovich A, Singh A. Grant TJ, et al. Among authors: singh a. Oncotarget. 2017 Sep 11;8(45):78556-78572. doi: 10.18632/oncotarget.20833. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108249 Free PMC article.

8

[No title available]

[No authors listed] [No authors listed] PMID: 35556793

9

Oncogenic K-ras "addiction" and synthetic lethality.

Singh A, Settleman J. Singh A, et al. Cell Cycle. 2009 Sep 1;8(17):2676-7. doi: 10.4161/cc.8.17.9336. Epub 2009 Sep 23. Cell Cycle. 2009. PMID: 19690457 Free PMC article.

10

A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N, Settleman J. Singh A, et al. Cancer Cell. 2009 Jun 2;15(6):489-500. doi: 10.1016/j.ccr.2009.03.022. Cancer Cell. 2009. PMID: 19477428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,945 results

Search Page

Filters